RedCell: Permanent bonds

Emerging Company Profile

RedCell: Permanent bonds

Many drugs fail in development because they are rapidly metabolized or cleared from the body too rapidly to have a therapeutic effect. Others must be given at such high doses that they cause toxicities and side effects.

RedCell Canada Inc. is combining the body's natural delivery packages - plasma proteins and red blood cells (RBCs) - with its Anchor chemistries to permanently bind therapeutic agents to the

Read the full 738 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE